Gilbert Technologies
Series A in 2023
Gilbert Technologies B.V. is a medical device company based in Naarden, the Netherlands, established in 2016. The company specializes in the development and commercialization of innovative inhaler devices aimed at treating lung diseases, managing pain, and facilitating vaccination. Its technology utilizes electrohydrodynamic atomization to create inhalation devices that enhance lung deposition characteristics for effective pulmonary medicine administration. Gilbert Technologies addresses various medical conditions, including cystic fibrosis, asthma, lung cancer, pulmonary arterial hypertension, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and non-CF bronchiectasis. Through its commitment to innovation, the company strives to improve the quality of life for patients by providing advanced therapeutic solutions in pulmonary medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.